Corrigendum to: �Novel and emerging mutations of SARS-CoV-2: Biomedical implications� Biomed. Pharmacother. 139 (2021) 111599 (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384X), (10.1016/j.biopha.2021.111599))

Mohammadi, E. and Shafiee, F. and Shahzamani, K. and Ranjbar, M.M. and Alibakhshi, A. and Ahangarzadeh, S. and Beikmohammadi, L. and Shariati, L. and Hooshmandi, S. and Ataei, B. and HaghjooyJavanmard, S. (2021) Corrigendum to: �Novel and emerging mutations of SARS-CoV-2: Biomedical implications� Biomed. Pharmacother. 139 (2021) 111599 (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384X), (10.1016/j.biopha.2021.111599)). Biomedicine and Pharmacotherapy, 140.

[img]
Preview
Text
Corrigendum to “Novel and emerging mutations of SARS-CoV-2 Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599] (Biomedicine & Pharmacotherapy (2021) 139, (S075333222100384X), (10.1016j.biopha.2021.111599)).pdf

Download (257kB) | Preview
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....

Abstract

The authors regret the incorrect publication of affiliations of some of the authors in the original article. The correct affiliation of the authors are presented below: Elmira Mohammadia,b Fatemeh Shafieec Kiana Shahzamanid Mohammad Mehdi Ranjbare Abbas Alibakhshif Shahrzad Ahangarzadehg Leila Beikmohammadih,i Laleh Shariatij,k Soodeh Hooshmandil Behrooz Ataeim Shaghayegh HaghjooyJavanmarda a Applied Physiology Research Center, Cardiovascular Research Institute, Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran b Core Research Facilities, Isfahan University of Medical Sciences, Isfahan, Iran c Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran d Isfahan Gastroenterology and Hepatology Research Center (lGHRC), Isfahan University of medical sciences, Isfahan, Iran e Razi Vaccine and Serum Research Institute, Agricultural Research, Education, and Extension Organization (AREEO), Karaj, Iran f Molecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran g Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran h Department of Biochemistry, Erasmus University Medical Center, Rotterdam, The Netherlands i Stem Cell and Regenerative Medicine Center of Excellence, Tehran University of Medical Sciences, 14155-6559 Tehran, Iran j Biosensor Research Center, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran k Department of Biomaterials, Nanotechnology and Tissue Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran l Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran m Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran The authors would like to apologise for any inconvenience caused. © 2021

Item Type: Article
Additional Information: cited By 0
Uncontrolled Keywords: erratum
Subjects: QV Pharmacology
Depositing User: eprints admin
Date Deposited: 04 Sep 2021 08:18
Last Modified: 10 Oct 2021 06:50
URI: http://eprints.iums.ac.ir/id/eprint/39081

Actions (login required)

View Item View Item